{"id":"https://openalex.org/W2043379639","doi":"https://doi.org/10.1016/s0028-3908(00)00142-8","title":"PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway","display_name":"PDE4 inhibitors induce emesis in ferrets via a noradrenergic pathway","alternate_titles":[],"publication_year":2001,"publication_date":"2001-01-01","ids":{"openalex":"https://openalex.org/W2043379639","doi":"https://doi.org/10.1016/s0028-3908(00)00142-8","mag":"2043379639","pmid":"https://pubmed.ncbi.nlm.nih.gov/11114405"},"language":"en","primary_location":{"id":"doi:10.1016/s0028-3908(00)00142-8","doi":"https://doi.org/10.1016/s0028-3908(00)00142-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(00)00142-8","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2043379639"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053637393","display_name":"Annette Robichaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. Robichaud","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8. annette_robichaud@merck.com","Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8. annette_robichaud@merck.com","institution_ids":["https://openalex.org/I4210095507"]},{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013068782","display_name":"Chantal Savoie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Savoie","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080128864","display_name":"Panagiota B. Stamatiou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P.B. Stamatiou","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112314474","display_name":"F.D. Tattersall","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F.D. Tattersall","raw_affiliation_strings":["Merck Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Harlow, Essex, CM20 2QR, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck Sharp and Dohme, Neuroscience Research Centre, Terlings Park, Harlow, Essex, CM20 2QR, UK","institution_ids":["https://openalex.org/I4210087189"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100766430","display_name":"C C Chan","orcid":"https://orcid.org/0009-0008-2041-6907","observed_orcids":["https://orcid.org/0009-0008-2041-6907"]},"institutions":[{"id":"https://openalex.org/I4210095507","display_name":"Merck Canada Inc. (Canada)","ror":"https://ror.org/00rz3ed53","country_code":"CA","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210095507"]}],"countries":["CA"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C.C. Chan","raw_affiliation_strings":["Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire, Dorval, Quebec, Canada H9R 4P8","institution_ids":["https://openalex.org/I4210095507"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053637393"],"corresponding_institution_ids":["https://openalex.org/I4210095507"],"apc_list":{"value":4300,"currency":"USD","value_usd":4300},"apc_paid":null,"fwci":1.4105,"has_fulltext":false,"cited_by_count":131,"citation_normalized_percentile":{"value":0.78923803,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"40","issue":"2","first_page":"262","last_page":"269"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12434","display_name":"Phosphodiesterase function and regulation","score":0.7910000085830688,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.15860000252723694,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11905","display_name":"Veterinary Pharmacology and Anesthesia","score":0.006899999920278788,"subfield":{"id":"https://openalex.org/subfields/3404","display_name":"Small Animals"},"field":{"id":"https://openalex.org/fields/34","display_name":"Veterinary"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phosphodiesterase-4-inhibitors","display_name":"phosphodiesterase-4 inhibitors","score":0.9190000295639038},{"id":"https://openalex.org/keywords/vomiting","display_name":"vomiting","score":0.9010000228881836},{"id":"https://openalex.org/keywords/alpha2-adrenergic-receptors","display_name":"alpha2-adrenoceptors","score":0.9150000214576721},{"id":"https://openalex.org/keywords/noradrenergic-pathways","display_name":"noradrenergic pathways","score":0.9869999885559082},{"id":"https://openalex.org/keywords/ferrets","display_name":"ferrets","score":0.753000020980835},{"id":"https://openalex.org/keywords/yohimbine","display_name":"yohimbine","score":0.8809999823570251},{"id":"https://openalex.org/keywords/clonidine","display_name":"clonidine","score":0.8989999890327454},{"id":"https://openalex.org/keywords/rolipram","display_name":"rolipram","score":0.7789999842643738},{"id":"https://openalex.org/keywords/anesthesia-duration","display_name":"anesthesia duration","score":0.7009999752044678},{"id":"https://openalex.org/keywords/ketamine-xylazine","display_name":"ketamine-xylazine","score":0.8600000143051147},{"id":"https://openalex.org/keywords/emetic-reflex","display_name":"emetic reflex","score":0.6269999742507935}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6584599614143372},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.429220974445343},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35163629055023193},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33880335092544556},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22102227807044983}],"mesh":[{"descriptor_ui":"D000316","descriptor_name":"Adrenergic alpha-Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000317","descriptor_name":"Adrenergic alpha-Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000758","descriptor_name":"Anesthesia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005289","descriptor_name":"Ferrets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010726","descriptor_name":"Phosphodiesterase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D015105","descriptor_name":"3',5'-Cyclic-AMP Phosphodiesterases","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018340","descriptor_name":"Receptors, Adrenergic, alpha-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018341","descriptor_name":"Receptors, Adrenergic, alpha-2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020889","descriptor_name":"Rolipram","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054703","descriptor_name":"Cyclic Nucleotide Phosphodiesterases, Type 4","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0028-3908(00)00142-8","doi":"https://doi.org/10.1016/s0028-3908(00)00142-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0028-3908(00)00142-8","pdf_url":null,"source":{"id":"https://openalex.org/S160566677","display_name":"Neuropharmacology","issn_l":"0028-3908","issn":["0028-3908","1873-7064"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:11114405","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11114405","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W9911003","https://openalex.org/W24710068","https://openalex.org/W403712192","https://openalex.org/W584497286","https://openalex.org/W1480702407","https://openalex.org/W1854471495","https://openalex.org/W1881428548","https://openalex.org/W1970774232","https://openalex.org/W1994422954","https://openalex.org/W1999964462","https://openalex.org/W2002608239","https://openalex.org/W2005181906","https://openalex.org/W2009772232","https://openalex.org/W2029232731","https://openalex.org/W2034213700","https://openalex.org/W2039761825","https://openalex.org/W2048497209","https://openalex.org/W2055419143","https://openalex.org/W2127853200","https://openalex.org/W2237040084","https://openalex.org/W2248778667","https://openalex.org/W2268066485","https://openalex.org/W2276257934","https://openalex.org/W2292415867","https://openalex.org/W2462506153","https://openalex.org/W2791114118","https://openalex.org/W4238981034","https://openalex.org/W4285719527","https://openalex.org/W4407200465","https://openalex.org/W6691149085","https://openalex.org/W6693519401","https://openalex.org/W6719108904","https://openalex.org/W6877234661"],"related_works":["https://openalex.org/W2068788937","https://openalex.org/W1999964462","https://openalex.org/W2292415867","https://openalex.org/W4200526713","https://openalex.org/W2000977076","https://openalex.org/W2065495381","https://openalex.org/W1994422954","https://openalex.org/W2069294892","https://openalex.org/W2129558854","https://openalex.org/W2909818915"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2043379639","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
